Expression and hypermethylation of p27kip1 in hepatocarcinogenesis

World Journal of Gastroenterology

Volumn 11, Issue 29, 2005, Pages 4587-4591

  Lei, Pu Ping ^a   Zhang, Zong Ji ^a   Shen, Li Juan ^a   Li, Jin Yu ^a   Zou, Qiong ^a   Zhang, Hua Xian ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Hypermethylation; Immunohistochemical staining; In situ hybridization; p27kip''1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; PROTEIN P27;

ARTICLE; CANCER STAGING; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRECANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN METHYLATION; RNA TRANSCRIPTION;

EID: 23844546638     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i29.4587     Document Type: Article

References (23)

1. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66
2. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M. Expression and prognostic roles of the G1-S modulators in hepatocellularcarcinoma: p27 independently predicts the recurrence. Hepatology 1999; 30: 90-99
3. kip1 gene in the hepatocellular carcinoma. Cancer Lett 2000; 153: 169-173
4. Hui AM, Sun L, Kanai Y, Sakamoto M, Hirohashi S. Reduced p27Kip1 expression in hepatocellular carcinomas. Cancer Lett 1998; 132: 67-73
5. Paulsen M, Ferguson-Smith AC. DNA methylation in genomic imprinting, development and disease. J Pathol 2001; 195: 97-110
6. Curradi M, Izzo A, Badaracco G, Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol 2002; 22: 3157-3173
7. Tsujie M, Yamamoto H, Tomita N, Sugita Y, Ohue M, Sakita I, Tamaki Y, Sekimoto M, Doki Y, Inoue M, Matsuura N, Monden T, Shiozaki H, Monden M. Expression of tumor suppressor gene p16(INK4) products in primary gastric cancer. Oncology 2000; 58: 126-136
8. Nakamura M, Yonekawa Y, Kleihues P, Ohgaki H. Promoter hyper methylation of the RB1 gene in glioblastomas. Lab Invest 2001; 81: 77-82
9. Konishi N, Nakamura M, Kishi M, Nishimine M, Ishida E, Shimada K. DNA hypermethylation status of multiple genes in prostate adenocarcinomas. Jpn J Cancer Res 2002; 93: 767-773
10. Zhao JG, Wu AG, Huang ZH, Yang JH. Expression of p27 and its clinical significance in colorectal carcinomas. Chin Ger J Clin Oncol 2002; 1: 129-131
11. Erickson LA, Jin L, Wollan P, Thompson GB, Heerden JA, Lloyd RV. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol 1999; 23: 288-295
12. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826
13. Nakamura M, Watanabe T, Klangby U, Asker C, Wiman K. p14 Deletion and Methylation in genetic Pathways to Glioblastomas. Brain Pathol 2001; 11: 159-168
14. INK4a Genes in primary Central Nervous System Lymphomas. Cancer Res 2001; 61: 6335-6339
15. Tannapfel A, Grund D, Katalinic A, Uhlmann D, Kocherling F, Haugwitz U, Wasner M, Hauss J, Engeland K, Wittekind C. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer 2000; 89: 350-355
16. Fiorentino M, Altimari A, D'rrico A, Cukor B, Barozzi C, Loda M, Grifioni WF. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin Cancer Res 2000; 6: 3966-3972
17. Nitti D, Belluco C, Mammano E, Marchet A, Ambrosi A, Mencarelli R, Segato P, Lise M. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Surg Oncol 2002; 81: 167-175
18. Anastasiadis AG, Calvo-Sanchez D, Franke KH, Ebert T, Heydthausen M, Schulz WA, Burchardt M, Gerharz CD. p27KIP1 expression in human renal cell cancers: implications for clinical outcome. Anticancer Res 2003; 23: 217-221
19. Filipits M, Puhalla H, Wrba F. Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma. Anticancer Res 2003; 23: 675-679
20. Qian X, Jin L, Kulig E, Lloyd RV. DNA methylation regulates p27kip1 expression in rodent pituitary cell lines. Am J Pathol 1998; 153: 1475-1482
21. Worm J, Bartkova J, Kirkin AF, Straten P, Zeuthen J, Bartek J, Guldberg P. Aberrant p27Kip1 promoter methylation in malignant melanoma. Oncogene 2000; 19: 5111-5115
22. Nakatsuka S, Liu A, Yao M, Takakuwa T, Tomita Y, Hoshihiko Y, Nishiu M, Aozasa K. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies. Int J Oncol 2003; 22: 561-568
23. Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF, Zhu JD. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res 2003; 13: 319-333